Terms: = Brain cancer AND B2M, P61769, 567, ENSG00000166710 AND Diagnosis
18 results:
1. Towards a Clearer Causal Question Underlying the Association Between cancer and Dementia.
Rojas-Saunero LP; van der Willik KD; Schagen SB; Ikram MA; Swanson SA
Epidemiology; 2024 May; 35(3):281-288. PubMed ID: 38442423
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Features of Resected Melanoma brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
3. Base MRI Imaging Characteristics of Meningioma Patients to Discuss the WHO Classification of brain Invasion Otherwise Benign Meningiomas.
Luo X; Jiang H; Liu XJ; Zhang Z; Deng K; Lin F; Jiang J; Wang YL; Yu J
Technol Cancer Res Treat; 2023; 22():15330338231171470. PubMed ID: 37264676
[TBL] [Abstract] [Full Text] [Related]
4. Management of Patients with Spine Tumors Strengthened by a Dedicated Multidisciplinary Spine Tumor Board: A 15-Year Single-Institutional Experience.
Mann M; Annable N; Emch TM; Wu J; Chao ST; Benzel E; Winkelman R; Angelov L
World Neurosurg; 2023 Jul; 175():e397-e405. PubMed ID: 37011761
[TBL] [Abstract] [Full Text] [Related]
5. Pooled Analysis of Meningioma Risk Following Treatment for Childhood cancer.
Withrow DR; Anderson H; Armstrong GT; Hawkins M; Journy N; Neglia JP; de Vathaire F; Tucker MA; Inskip PD; Brenner AV; Stovall MA; Diallo I; Berrington de Gonzalez A; Veiga LHS
JAMA Oncol; 2022 Dec; 8(12):1756-1764. PubMed ID: 36201196
[TBL] [Abstract] [Full Text] [Related]
6. SGEResU-Net for brain tumor segmentation.
Liu D; Sheng N; He T; Wang W; Zhang J; Zhang J
Math Biosci Eng; 2022 Mar; 19(6):5576-5590. PubMed ID: 35603369
[TBL] [Abstract] [Full Text] [Related]
7. IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation.
Barresi V; Simbolo M; Mafficini A; Martini M; Calicchia M; Piredda ML; Ciaparrone C; Bonizzato G; Ammendola S; Caffo M; Pinna G; Sala F; Lawlor RT; Ghimenton C; Scarpa A
Acta Neuropathol Commun; 2021 Dec; 9(1):200. PubMed ID: 34952640
[TBL] [Abstract] [Full Text] [Related]
8. b2m overexpression correlates with malignancy and immune signatures in human gliomas.
Zhang H; Cui B; Zhou Y; Wang X; Wu W; Wang Z; Dai Z; Cheng Q; Yang K
Sci Rep; 2021 Mar; 11(1):5045. PubMed ID: 33658560
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of
Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386
[TBL] [Abstract] [Full Text] [Related]
10. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD;
Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688
[TBL] [Abstract] [Full Text] [Related]
11. Photodynamic therapy in the treatment of brain tumours. A feasibility study.
Vanaclocha V; Sureda M; Azinovic I; Rebollo J; Cañón R; Sapena NS; Cases FG; Brugarolas A
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):422-7. PubMed ID: 26073912
[TBL] [Abstract] [Full Text] [Related]
12. Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival.
Manapov F; Klöcking S; Niyazi M; Levitskiy V; Belka C; Hildebrandt G; Fietkau R; Klautke G
J Neurooncol; 2012 Sep; 109(2):309-14. PubMed ID: 22610939
[TBL] [Abstract] [Full Text] [Related]
13. Increased prevalence of chronic fatigue among survivors of childhood cancers: a population-based study.
Jóhannsdóttir IM; Hjermstad MJ; Moum T; Wesenberg F; Hjorth L; Schrøder H; Mört S; Jónmundsson G; Loge JH
Pediatr Blood Cancer; 2012 Mar; 58(3):415-20. PubMed ID: 21425447
[TBL] [Abstract] [Full Text] [Related]
14. Claudin-6 is of limited sensitivity and specificity for the diagnosis of atypical teratoid/rhabdoid tumors.
Antonelli M; Hasselblatt M; Haberler C; Di Giannatale A; Garrè ML; Donofrio V; Lauriola L; Ridola V; Arcella A; Frühwald M; Giangaspero F
Brain Pathol; 2011 Sep; 21(5):558-63. PubMed ID: 21261775
[TBL] [Abstract] [Full Text] [Related]
15. Congenital glioblastoma.
Milano GM; Cerri C; Ferruzzi V; Capolsini I; Mastrodicasa E; Genitori L; Aversa F
Pediatr Blood Cancer; 2009 Jul; 53(1):124-6. PubMed ID: 19309717
[TBL] [Abstract] [Full Text] [Related]
16. cancer's impact on employment and earnings--a population-based study from Norway.
Syse A; Tretli S; Kravdal Ø
J Cancer Surviv; 2008 Sep; 2(3):149-58. PubMed ID: 18792789
[TBL] [Abstract] [Full Text] [Related]
17. Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia.
Armstrong GT; Phillips PC; Rorke-Adams LB; Judkins AR; Localio AR; Fisher MJ
Cancer; 2006 Oct; 107(7):1597-606. PubMed ID: 16955507
[TBL] [Abstract] [Full Text] [Related]
18. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
[TBL] [Abstract] [Full Text] [Related]
